...
aytu-img

Aytu BioScience Inc, Common Stock

AYTU

NAQ

$1.414

+$0.03

(2.17%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$8.49M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
25.83K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-1.40
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.3 L
$3.45 H
$1.414

About Aytu BioScience Inc, Common Stock

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years of age and above, and Cotempla XR-ODT for patients from six to seventeen years old. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameAYTUSectorS&P500
1-Week Return-4.17%-2.12%-2.22%
1-Month Return-7.38%-3.42%0.07%
3-Month Return-43.67%-11.13%3.71%
6-Month Return-50.71%-5.74%8.04%
1-Year Return-51.75%3.97%26.32%
3-Year Return-95.61%1.05%29.42%
5-Year Return-99.19%34.37%83.36%
10-Year Return-100%97.88%185.56%

Financials

Jun '20Jun '21Jun '22Jun '23Jun '245YR TREND
Total Revenue27.63M65.63M96.67M107.40M81.00M[{"date":"2020-06-30","value":25.73,"profit":true},{"date":"2021-06-30","value":61.11,"profit":true},{"date":"2022-06-30","value":90.01,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":75.42,"profit":true}]
Cost of Revenue7.55M36.43M44.39M40.77M26.42M[{"date":"2020-06-30","value":17.02,"profit":true},{"date":"2021-06-30","value":82.08,"profit":true},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":91.85,"profit":true},{"date":"2024-06-30","value":59.51,"profit":true}]
Gross Profit20.08M29.20M52.28M66.63M54.59M[{"date":"2020-06-30","value":30.13,"profit":true},{"date":"2021-06-30","value":43.82,"profit":true},{"date":"2022-06-30","value":78.47,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":81.92,"profit":true}]
Gross Margin72.67%44.49%54.08%62.04%67.39%[{"date":"2020-06-30","value":100,"profit":true},{"date":"2021-06-30","value":61.23,"profit":true},{"date":"2022-06-30","value":74.43,"profit":true},{"date":"2023-06-30","value":85.38,"profit":true},{"date":"2024-06-30","value":92.74,"profit":true}]
Operating Expenses41.01M67.44M88.39M78.96M60.57M[{"date":"2020-06-30","value":46.4,"profit":true},{"date":"2021-06-30","value":76.3,"profit":true},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":89.34,"profit":true},{"date":"2024-06-30","value":68.53,"profit":true}]
Operating Income(20.94M)(38.24M)37.22M(17.07M)(5.25M)[{"date":"2020-06-30","value":-56.25,"profit":false},{"date":"2021-06-30","value":-102.75,"profit":false},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":-45.86,"profit":false},{"date":"2024-06-30","value":-14.12,"profit":false}]
Total Non-Operating Income/Expense---(4.95M)(13.61M)[{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":-494900000,"profit":false},{"date":"2024-06-30","value":-1361400000,"profit":false}]
Pre-Tax Income(13.62M)(58.03M)(110.28M)(17.05M)(14.08M)[{"date":"2020-06-30","value":-1362067900,"profit":false},{"date":"2021-06-30","value":-5803000000,"profit":false},{"date":"2022-06-30","value":-11028300000,"profit":false},{"date":"2023-06-30","value":-1705100000,"profit":false},{"date":"2024-06-30","value":-1407600000,"profit":false}]
Income Taxes(9.92M)259.00K(110.00K)(57.00K)1.77M[{"date":"2020-06-30","value":-561.15,"profit":false},{"date":"2021-06-30","value":14.65,"profit":true},{"date":"2022-06-30","value":-6.22,"profit":false},{"date":"2023-06-30","value":-3.22,"profit":false},{"date":"2024-06-30","value":100,"profit":true}]
Income After Taxes---(16.99M)(15.84M)[{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":-1699400000,"profit":false},{"date":"2024-06-30","value":-1584400000,"profit":false}]
Income From Continuous Operations(13.62M)(58.29M)(110.17M)(17.05M)(15.84M)[{"date":"2020-06-30","value":-1362067900,"profit":false},{"date":"2021-06-30","value":-5828900000,"profit":false},{"date":"2022-06-30","value":-11017300000,"profit":false},{"date":"2023-06-30","value":-1705100000,"profit":false},{"date":"2024-06-30","value":-1584400000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Net Income(3.70M)(58.29M)(108.78M)(17.05M)(15.84M)[{"date":"2020-06-30","value":-369960300,"profit":false},{"date":"2021-06-30","value":-5828900000,"profit":false},{"date":"2022-06-30","value":-10878000000,"profit":false},{"date":"2023-06-30","value":-1705000000,"profit":false},{"date":"2024-06-30","value":-1584400000,"profit":false}]
EPS (Diluted)(96.20)(65.20)(76.20)(5.03)(2.86)[{"date":"2020-06-30","value":-9620,"profit":false},{"date":"2021-06-30","value":-6520,"profit":false},{"date":"2022-06-30","value":-7620,"profit":false},{"date":"2023-06-30","value":-503,"profit":false},{"date":"2024-06-30","value":-286,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

AYTU
Cash Ratio 0.33
Current Ratio 0.99
Quick Ratio 0.80

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AYTU
ROA (LTM) -1.06%
ROE (LTM) -47.24%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AYTU
Debt Ratio Lower is generally better. Negative is bad. 0.74
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.26

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AYTU
Trailing PE NM
Forward PE 2.32
P/S (TTM) 0.10
P/B 0.29
Price/FCF NM
EV/R 0.06
EV/Ebitda 0.69
PEG NM

FAQs

What is Aytu BioScience Inc share price today?

Aytu BioScience Inc (AYTU) share price today is $1.414

Can Indians buy Aytu BioScience Inc shares?

Yes, Indians can buy shares of Aytu BioScience Inc (AYTU) on Vested. To buy Aytu BioScience Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AYTU stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Aytu BioScience Inc be purchased?

Yes, you can purchase fractional shares of Aytu BioScience Inc (AYTU) via the Vested app. You can start investing in Aytu BioScience Inc (AYTU) with a minimum investment of $1.

How to invest in Aytu BioScience Inc shares from India?

You can invest in shares of Aytu BioScience Inc (AYTU) via Vested in three simple steps:

  • Click on Sign Up or Invest in AYTU stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Aytu BioScience Inc shares
What is Aytu BioScience Inc 52-week high and low stock price?

The 52-week high price of Aytu BioScience Inc (AYTU) is $3.45. The 52-week low price of Aytu BioScience Inc (AYTU) is $1.3.

What is Aytu BioScience Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Aytu BioScience Inc (AYTU) is

What is Aytu BioScience Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Aytu BioScience Inc (AYTU) is 0.29

What is Aytu BioScience Inc dividend yield?

The dividend yield of Aytu BioScience Inc (AYTU) is 0.00%

What is the Market Cap of Aytu BioScience Inc?

The market capitalization of Aytu BioScience Inc (AYTU) is $8.49M

What is Aytu BioScience Inc’s stock symbol?

The stock symbol (or ticker) of Aytu BioScience Inc is AYTU

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top